Potential benefits of implementing the technology «endpoint» to detect RNA virus SARS-COV-2 in field conditions: prospective study

OBJECTIVE: the assessment of potential benefits of implementing hardware technologies, available for supply in the Russian Armed Forces to hold mass rapid screening test of servicemen for RNA virus SARS-CoV-2 by PCR on «endpoint» in field conditions.

MATERIALS AND METHODS: PCR on «endpoint» was applied according to the protocol of RNA virus detection by the set of test system PCR-RV «PolivirSARS-CoV-2» with extraction reagent «RNA-express», joint production of LLC NPF «Litech» and the Federal Research and Clinical Centre of Physical-Chemical Medicine FMBA. The biomaterial for the research was 157 samples of nasal-pharyngeal smears, taken from patients with clinical symptoms of respiratory disease who had contacts with COVID-19. Statistics. The data received from pilot studies had standard statistical processing in the program «Statistica 6,0». Non-parametric Pearson’s chi-square (c2) criteria was used to assess the significance of different observation frequencies of the studied feature in independent groups. Probability p≤0,05 and higher was considered sufficient to conclude statistical importance of the differences received.

RESULTS: It is stated that out of 157 biomaterial samples, assessed for the content of SARS-CoV-2 virus’s genetic markers by PCR on «endpoint» and PCR «Realtime», 141 and 146 samples, respectively, turned out to be positive. In addition, there were no statistically important differences between the received data in these methods (c2=1,013, р=0,31).

DISCUSSION: It is shown that comparative characteristics of the studied methods in laboratory SARS-Соv-2 virus diagnostics suggested the possibility of detecting specific segment of the virus genome by PCR «endpoint» technology, using expendable reagents, made for PCR «Realtime».

1. Döhla M., Boesecke C., B Schulte, Diegmann C., Sib E., Richter E., Eschbach-Bludau M., S Aldabbagh, Marx B., EisHübinger A-M., Schmithausen R.M., Streeck H. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity // Public health. 2020. Vol. 182. P. 170–172. doi: 10.1016/j.puhe.2020.04.009.

2. Ravi N. Cortade D., Ng E., Wang Sh. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape // Biosensors and bioelectronics. 2020. Vol. 165. P. 24–54. doi: 10.1016/j.bios.2020.112454.

3. Platonov A.E. Statistical analysis in medicine and biology: tasks, terminology, logic, computer methods. Moscow: Publishing house of the Russian Academy of Medical Sciences, 2000. 52 p. (In Russ.).